Neurokinin	B:C0068603
3	I:C0068603
Receptor	I:C0068603
Antagonism	O
Reveals	O
Roles	O
for	O
Neurokinin	O
B	I:C0027847
in	O
the	O
Regulation	O
of	O
Gonadotropin	O
Secretion	I:C1819179
and	O
Hot	O
Flashes	I:C0600142
in	O
Postmenopausal	O
Women	O
.	O

Neurokinin	O
3	I:C0068603
Receptor	I:C0068603
Antagonism	O
Reveals	O
Roles	O
for	O
Neurokinin	B:C0027847
B	I:C0027847
in	O
the	O
Regulation	O
of	O
Gonadotropin	O
Secretion	I:C1819179
and	O
Hot	O
Flashes	I:C0600142
in	O
Postmenopausal	O
Women	O
.	O

Neurokinin	O
3	I:C0068603
Receptor	I:C0068603
Antagonism	O
Reveals	O
Roles	O
for	O
Neurokinin	O
B	I:C0027847
in	O
the	O
Regulation	B:C1327622
of	O
Gonadotropin	O
Secretion	I:C1819179
and	O
Hot	O
Flashes	I:C0600142
in	O
Postmenopausal	O
Women	O
.	O

Neurokinin	O
3	I:C0068603
Receptor	I:C0068603
Antagonism	O
Reveals	O
Roles	O
for	O
Neurokinin	O
B	I:C0027847
in	O
the	O
Regulation	O
of	O
Gonadotropin	B:C1819179
Secretion	I:C1819179
and	O
Hot	O
Flashes	I:C0600142
in	O
Postmenopausal	O
Women	O
.	O

Neurokinin	O
3	I:C0068603
Receptor	I:C0068603
Antagonism	O
Reveals	O
Roles	O
for	O
Neurokinin	O
B	I:C0027847
in	O
the	O
Regulation	O
of	O
Gonadotropin	O
Secretion	I:C1819179
and	O
Hot	B:C0600142
Flashes	I:C0600142
in	O
Postmenopausal	O
Women	O
.	O

Neurokinin	O
3	I:C0068603
Receptor	I:C0068603
Antagonism	O
Reveals	O
Roles	O
for	O
Neurokinin	O
B	I:C0027847
in	O
the	O
Regulation	O
of	O
Gonadotropin	O
Secretion	I:C1819179
and	O
Hot	O
Flashes	I:C0600142
in	O
Postmenopausal	B:C0232970
Women	O
.	O

Neurokinin	O
3	I:C0068603
Receptor	I:C0068603
Antagonism	O
Reveals	O
Roles	O
for	O
Neurokinin	O
B	I:C0027847
in	O
the	O
Regulation	O
of	O
Gonadotropin	O
Secretion	I:C1819179
and	O
Hot	O
Flashes	I:C0600142
in	O
Postmenopausal	O
Women	B:C0043210
.	O

Neurokinin	B:C0027847
B	I:C0027847
(	O
Neurokinin	O
B	I:C0027847
)	O
and	O
kisspeptin	O
are	O
obligate	O
for	O
normal	O
gonadotropin	O
secretion	I:C1819179
,	O
and	O
links	O
between	O
GnRH	O
pulsatility	O
and	O
vasomotor	O
symptoms	O
have	O
been	O
proposed	O
.	O

Neurokinin	O
B	I:C0027847
(	O
Neurokinin	B:C0027847
B	I:C0027847
)	O
and	O
kisspeptin	O
are	O
obligate	O
for	O
normal	O
gonadotropin	O
secretion	I:C1819179
,	O
and	O
links	O
between	O
GnRH	O
pulsatility	O
and	O
vasomotor	O
symptoms	O
have	O
been	O
proposed	O
.	O

Neurokinin	O
B	I:C0027847
(	O
Neurokinin	O
B	I:C0027847
)	O
and	O
kisspeptin	B:C3146273
are	O
obligate	O
for	O
normal	O
gonadotropin	O
secretion	I:C1819179
,	O
and	O
links	O
between	O
GnRH	O
pulsatility	O
and	O
vasomotor	O
symptoms	O
have	O
been	O
proposed	O
.	O

Neurokinin	O
B	I:C0027847
(	O
Neurokinin	O
B	I:C0027847
)	O
and	O
kisspeptin	O
are	O
obligate	O
for	O
normal	O
gonadotropin	B:C1819179
secretion	I:C1819179
,	O
and	O
links	O
between	O
GnRH	O
pulsatility	O
and	O
vasomotor	O
symptoms	O
have	O
been	O
proposed	O
.	O

Neurokinin	O
B	I:C0027847
(	O
Neurokinin	O
B	I:C0027847
)	O
and	O
kisspeptin	O
are	O
obligate	O
for	O
normal	O
gonadotropin	O
secretion	I:C1819179
,	O
and	O
links	O
between	O
GnRH	B:C0023610
pulsatility	O
and	O
vasomotor	O
symptoms	O
have	O
been	O
proposed	O
.	O

Using	O
a	O
selective	O
NKB	B:C0068603
receptor	I:C0068603
(	O
NK3R	O
)	O
antagonist	O
,	O
the	O
role	O
of	O
Neurokinin	O
B	I:C0027847
in	O
the	O
hypergonadotropic	O
state	O
in	O
menopausal	O
women	O
was	O
explored	O
.	O

Using	O
a	O
selective	O
NKB	O
receptor	I:C0068603
(	O
NK3R	B:C0068603
)	O
antagonist	O
,	O
the	O
role	O
of	O
Neurokinin	O
B	I:C0027847
in	O
the	O
hypergonadotropic	O
state	O
in	O
menopausal	O
women	O
was	O
explored	O
.	O

Using	O
a	O
selective	O
NKB	O
receptor	I:C0068603
(	O
NK3R	O
)	O
antagonist	B:C0243076
,	O
the	O
role	O
of	O
Neurokinin	O
B	I:C0027847
in	O
the	O
hypergonadotropic	O
state	O
in	O
menopausal	O
women	O
was	O
explored	O
.	O

Using	O
a	O
selective	O
NKB	O
receptor	I:C0068603
(	O
NK3R	O
)	O
antagonist	O
,	O
the	O
role	O
of	O
Neurokinin	B:C0027847
B	I:C0027847
in	O
the	O
hypergonadotropic	O
state	O
in	O
menopausal	O
women	O
was	O
explored	O
.	O

Using	O
a	O
selective	O
NKB	O
receptor	I:C0068603
(	O
NK3R	O
)	O
antagonist	O
,	O
the	O
role	O
of	O
Neurokinin	O
B	I:C0027847
in	O
the	O
hypergonadotropic	O
state	O
in	O
menopausal	B:C0025320
women	O
was	O
explored	O
.	O

Using	O
a	O
selective	O
NKB	O
receptor	I:C0068603
(	O
NK3R	O
)	O
antagonist	O
,	O
the	O
role	O
of	O
Neurokinin	O
B	I:C0027847
in	O
the	O
hypergonadotropic	O
state	O
in	O
menopausal	O
women	B:C0043210
was	O
explored	O
.	O

Eleven	O
postmenopausal	B:C0232970
women	O
were	O
administered	O
the	O
NK3R	O
antagonist	O
MLE4901	O
,	O
40	O
mg	O
twice	O
daily	O
orally	O
for	O
7	O
days	O
.	O

Eleven	O
postmenopausal	O
women	B:C0043210
were	O
administered	O
the	O
NK3R	O
antagonist	O
MLE4901	O
,	O
40	O
mg	O
twice	O
daily	O
orally	O
for	O
7	O
days	O
.	O

Eleven	O
postmenopausal	O
women	O
were	O
administered	O
the	O
NK3R	B:C0068603
antagonist	O
MLE4901	O
,	O
40	O
mg	O
twice	O
daily	O
orally	O
for	O
7	O
days	O
.	O

Eleven	O
postmenopausal	O
women	O
were	O
administered	O
the	O
NK3R	O
antagonist	B:C0243076
MLE4901	O
,	O
40	O
mg	O
twice	O
daily	O
orally	O
for	O
7	O
days	O
.	O

Eleven	O
postmenopausal	O
women	O
were	O
administered	O
the	O
NK3R	O
antagonist	O
MLE4901	B:C2975298
,	O
40	O
mg	O
twice	O
daily	O
orally	O
for	O
7	O
days	O
.	O

Eleven	O
postmenopausal	O
women	O
were	O
administered	O
the	O
NK3R	O
antagonist	O
MLE4901	O
,	O
40	O
mg	O
twice	O
daily	O
orally	B:C0442027
for	O
7	O
days	O
.	O

10	O
-	O
min	O
blood	B:C0190979
sampling	I:C0190979
for	O
8	O
h	O
was	O
performed	O
before	O
and	O
on	O
the	O
last	O
day	O
of	O
NK3R	O
antagonist	O
treatment	O
for	O
LH	O
pulsatility	O
analysis	O
with	O
kisspeptin	O
-	I:C1721258
10	I:C1721258
(	O
0.3	O
µg	O
/kg	O
iv	O
bolus	O
)	O
administered	O
at	O
6	O
h	O
on	O
both	O
days	O
.	O

10	O
-	O
min	O
blood	O
sampling	I:C0190979
for	O
8	O
h	O
was	O
performed	O
before	O
and	O
on	O
the	O
last	O
day	O
of	O
NK3R	B:C0068603
antagonist	O
treatment	O
for	O
LH	O
pulsatility	O
analysis	O
with	O
kisspeptin	O
-	I:C1721258
10	I:C1721258
(	O
0.3	O
µg	O
/kg	O
iv	O
bolus	O
)	O
administered	O
at	O
6	O
h	O
on	O
both	O
days	O
.	O

10	O
-	O
min	O
blood	O
sampling	I:C0190979
for	O
8	O
h	O
was	O
performed	O
before	O
and	O
on	O
the	O
last	O
day	O
of	O
NK3R	O
antagonist	B:C0243076
treatment	O
for	O
LH	O
pulsatility	O
analysis	O
with	O
kisspeptin	O
-	I:C1721258
10	I:C1721258
(	O
0.3	O
µg	O
/kg	O
iv	O
bolus	O
)	O
administered	O
at	O
6	O
h	O
on	O
both	O
days	O
.	O

10	O
-	O
min	O
blood	O
sampling	I:C0190979
for	O
8	O
h	O
was	O
performed	O
before	O
and	O
on	O
the	O
last	O
day	O
of	O
NK3R	O
antagonist	O
treatment	O
for	O
LH	B:C0023607
pulsatility	O
analysis	O
with	O
kisspeptin	O
-	I:C1721258
10	I:C1721258
(	O
0.3	O
µg	O
/kg	O
iv	O
bolus	O
)	O
administered	O
at	O
6	O
h	O
on	O
both	O
days	O
.	O

10	O
-	O
min	O
blood	O
sampling	I:C0190979
for	O
8	O
h	O
was	O
performed	O
before	O
and	O
on	O
the	O
last	O
day	O
of	O
NK3R	O
antagonist	O
treatment	O
for	O
LH	O
pulsatility	O
analysis	B:C0936012
with	O
kisspeptin	O
-	I:C1721258
10	I:C1721258
(	O
0.3	O
µg	O
/kg	O
iv	O
bolus	O
)	O
administered	O
at	O
6	O
h	O
on	O
both	O
days	O
.	O

10	O
-	O
min	O
blood	O
sampling	I:C0190979
for	O
8	O
h	O
was	O
performed	O
before	O
and	O
on	O
the	O
last	O
day	O
of	O
NK3R	O
antagonist	O
treatment	O
for	O
LH	O
pulsatility	O
analysis	O
with	O
kisspeptin	B:C1721258
-	I:C1721258
10	I:C1721258
(	O
0.3	O
µg	O
/kg	O
iv	O
bolus	O
)	O
administered	O
at	O
6	O
h	O
on	O
both	O
days	O
.	O

Hot	B:C0600142
flash	I:C0600142
frequency	O
and	O
severity	O
were	O
self	O
-	O
reported	O
for	O
7	O
days	O
before	O
and	O
during	O
NK3R	O
antagonist	O
administration	O
.	O

Hot	O
flash	I:C0600142
frequency	O
and	O
severity	O
were	O
self	O
-	O
reported	O
for	O
7	O
days	O
before	O
and	O
during	O
NK3R	B:C0068603
antagonist	O
administration	O
.	O

Hot	O
flash	I:C0600142
frequency	O
and	O
severity	O
were	O
self	O
-	O
reported	O
for	O
7	O
days	O
before	O
and	O
during	O
NK3R	O
antagonist	B:C0243076
administration	O
.	O

Hot	O
flash	I:C0600142
frequency	O
and	O
severity	O
were	O
self	O
-	O
reported	O
for	O
7	O
days	O
before	O
and	O
during	O
NK3R	O
antagonist	O
administration	B:C1533734
.	O

LH	B:C0023607
fell	O
from	O
29.3	O
±	O
4.1	O
to	O
24.4	O
±	O
3.8	O
IU/l	O
(	O
p	O
<	O
0.05	O
)	O
after	O
7	O
days	O
of	O
NK3R	O
antagonist	O
,	O
with	O
no	O
change	O
in	O
FSH	O
.	O

LH	O
fell	O
from	O
29.3	O
±	O
4.1	O
to	O
24.4	O
±	O
3.8	O
IU/l	O
(	O
p	O
<	O
0.05	O
)	O
after	O
7	O
days	O
of	O
NK3R	B:C0068603
antagonist	O
,	O
with	O
no	O
change	O
in	O
FSH	O
.	O

LH	O
fell	O
from	O
29.3	O
±	O
4.1	O
to	O
24.4	O
±	O
3.8	O
IU/l	O
(	O
p	O
<	O
0.05	O
)	O
after	O
7	O
days	O
of	O
NK3R	O
antagonist	B:C0243076
,	O
with	O
no	O
change	O
in	O
FSH	O
.	O

LH	O
fell	O
from	O
29.3	O
±	O
4.1	O
to	O
24.4	O
±	O
3.8	O
IU/l	O
(	O
p	O
<	O
0.05	O
)	O
after	O
7	O
days	O
of	O
NK3R	O
antagonist	O
,	O
with	O
no	O
change	O
in	O
FSH	B:C0733758
.	O

Basal	O
(	O
nonpulsatile	B:C0243095
)	O
LH	O
secretion	O
was	O
reduced	O
(	O
549.0	O
±	O
70.8	O
vs.	O
366.1	O
±	O
92.1	O
IU	O
/	O
L/6	O
h	O
,	O
p	O
=	O
0.006	O
)	O
and	O
while	O
LH	O
pulse	O
frequency	O
did	O
not	O
change	O
in	O
the	O
group	O
as	O
a	O
whole	O
(	O
0.8	O
±	O
0.1	O
to	O
0.7	O
±	O
0.1	O
pulses	O
/h	O
,	O
ns	O
)	O
,	O
it	O
did	O
fall	O
in	O
the	O
8/11	O
women	O
with	O
hot	O
flashes	I:C0600142
,	O
(	O
1.0	O
±	O
0.1	O
to	O
0.7	O
±	O
0.1	O
pulses	O
/h	O
,	O
p	O
<	O
0.05	O
)	O
.	O

Basal	O
(	O
nonpulsatile	O
)	O
LH	B:C0023607
secretion	O
was	O
reduced	O
(	O
549.0	O
±	O
70.8	O
vs.	O
366.1	O
±	O
92.1	O
IU	O
/	O
L/6	O
h	O
,	O
p	O
=	O
0.006	O
)	O
and	O
while	O
LH	O
pulse	O
frequency	O
did	O
not	O
change	O
in	O
the	O
group	O
as	O
a	O
whole	O
(	O
0.8	O
±	O
0.1	O
to	O
0.7	O
±	O
0.1	O
pulses	O
/h	O
,	O
ns	O
)	O
,	O
it	O
did	O
fall	O
in	O
the	O
8/11	O
women	O
with	O
hot	O
flashes	I:C0600142
,	O
(	O
1.0	O
±	O
0.1	O
to	O
0.7	O
±	O
0.1	O
pulses	O
/h	O
,	O
p	O
<	O
0.05	O
)	O
.	O

Basal	O
(	O
nonpulsatile	O
)	O
LH	O
secretion	B:C0036536
was	O
reduced	O
(	O
549.0	O
±	O
70.8	O
vs.	O
366.1	O
±	O
92.1	O
IU	O
/	O
L/6	O
h	O
,	O
p	O
=	O
0.006	O
)	O
and	O
while	O
LH	O
pulse	O
frequency	O
did	O
not	O
change	O
in	O
the	O
group	O
as	O
a	O
whole	O
(	O
0.8	O
±	O
0.1	O
to	O
0.7	O
±	O
0.1	O
pulses	O
/h	O
,	O
ns	O
)	O
,	O
it	O
did	O
fall	O
in	O
the	O
8/11	O
women	O
with	O
hot	O
flashes	I:C0600142
,	O
(	O
1.0	O
±	O
0.1	O
to	O
0.7	O
±	O
0.1	O
pulses	O
/h	O
,	O
p	O
<	O
0.05	O
)	O
.	O

Basal	O
(	O
nonpulsatile	O
)	O
LH	O
secretion	O
was	O
reduced	O
(	O
549.0	O
±	O
70.8	O
vs.	O
366.1	O
±	O
92.1	O
IU	O
/	O
L/6	O
h	O
,	O
p	O
=	O
0.006	O
)	O
and	O
while	O
LH	B:C0023607
pulse	O
frequency	O
did	O
not	O
change	O
in	O
the	O
group	O
as	O
a	O
whole	O
(	O
0.8	O
±	O
0.1	O
to	O
0.7	O
±	O
0.1	O
pulses	O
/h	O
,	O
ns	O
)	O
,	O
it	O
did	O
fall	O
in	O
the	O
8/11	O
women	O
with	O
hot	O
flashes	I:C0600142
,	O
(	O
1.0	O
±	O
0.1	O
to	O
0.7	O
±	O
0.1	O
pulses	O
/h	O
,	O
p	O
<	O
0.05	O
)	O
.	O

Basal	O
(	O
nonpulsatile	O
)	O
LH	O
secretion	O
was	O
reduced	O
(	O
549.0	O
±	O
70.8	O
vs.	O
366.1	O
±	O
92.1	O
IU	O
/	O
L/6	O
h	O
,	O
p	O
=	O
0.006	O
)	O
and	O
while	O
LH	O
pulse	O
frequency	O
did	O
not	O
change	O
in	O
the	O
group	O
as	O
a	O
whole	O
(	O
0.8	O
±	O
0.1	O
to	O
0.7	O
±	O
0.1	O
pulses	B:C0391850
/h	O
,	O
ns	O
)	O
,	O
it	O
did	O
fall	O
in	O
the	O
8/11	O
women	O
with	O
hot	O
flashes	I:C0600142
,	O
(	O
1.0	O
±	O
0.1	O
to	O
0.7	O
±	O
0.1	O
pulses	O
/h	O
,	O
p	O
<	O
0.05	O
)	O
.	O

Basal	O
(	O
nonpulsatile	O
)	O
LH	O
secretion	O
was	O
reduced	O
(	O
549.0	O
±	O
70.8	O
vs.	O
366.1	O
±	O
92.1	O
IU	O
/	O
L/6	O
h	O
,	O
p	O
=	O
0.006	O
)	O
and	O
while	O
LH	O
pulse	O
frequency	O
did	O
not	O
change	O
in	O
the	O
group	O
as	O
a	O
whole	O
(	O
0.8	O
±	O
0.1	O
to	O
0.7	O
±	O
0.1	O
pulses	O
/h	O
,	O
ns	O
)	O
,	O
it	O
did	O
fall	O
in	O
the	O
8/11	O
women	B:C0043210
with	O
hot	O
flashes	I:C0600142
,	O
(	O
1.0	O
±	O
0.1	O
to	O
0.7	O
±	O
0.1	O
pulses	O
/h	O
,	O
p	O
<	O
0.05	O
)	O
.	O

Basal	O
(	O
nonpulsatile	O
)	O
LH	O
secretion	O
was	O
reduced	O
(	O
549.0	O
±	O
70.8	O
vs.	O
366.1	O
±	O
92.1	O
IU	O
/	O
L/6	O
h	O
,	O
p	O
=	O
0.006	O
)	O
and	O
while	O
LH	O
pulse	O
frequency	O
did	O
not	O
change	O
in	O
the	O
group	O
as	O
a	O
whole	O
(	O
0.8	O
±	O
0.1	O
to	O
0.7	O
±	O
0.1	O
pulses	O
/h	O
,	O
ns	O
)	O
,	O
it	O
did	O
fall	O
in	O
the	O
8/11	O
women	O
with	O
hot	B:C0600142
flashes	I:C0600142
,	O
(	O
1.0	O
±	O
0.1	O
to	O
0.7	O
±	O
0.1	O
pulses	O
/h	O
,	O
p	O
<	O
0.05	O
)	O
.	O

Basal	O
(	O
nonpulsatile	O
)	O
LH	O
secretion	O
was	O
reduced	O
(	O
549.0	O
±	O
70.8	O
vs.	O
366.1	O
±	O
92.1	O
IU	O
/	O
L/6	O
h	O
,	O
p	O
=	O
0.006	O
)	O
and	O
while	O
LH	O
pulse	O
frequency	O
did	O
not	O
change	O
in	O
the	O
group	O
as	O
a	O
whole	O
(	O
0.8	O
±	O
0.1	O
to	O
0.7	O
±	O
0.1	O
pulses	O
/h	O
,	O
ns	O
)	O
,	O
it	O
did	O
fall	O
in	O
the	O
8/11	O
women	O
with	O
hot	O
flashes	I:C0600142
,	O
(	O
1.0	O
±	O
0.1	O
to	O
0.7	O
±	O
0.1	O
pulses	B:C0391850
/h	O
,	O
p	O
<	O
0.05	O
)	O
.	O

These	O
women	B:C0043210
also	O
reported	O
a	O
reduction	O
in	O
hot	O
flash	I:C0600142
frequency	O
(	O
3.4	O
±	O
1.2	O
to	O
1.0	O
±	O
0.6	O
hot	O
flashes	I:C0600142
/	O
day	O
,	O
p	O
=	O
0.008	O
)	O
whist	O
taking	O
NK3R	O
antagonist	O
.	O

These	O
women	O
also	O
reported	O
a	O
reduction	O
in	O
hot	B:C0600142
flash	I:C0600142
frequency	O
(	O
3.4	O
±	O
1.2	O
to	O
1.0	O
±	O
0.6	O
hot	O
flashes	I:C0600142
/	O
day	O
,	O
p	O
=	O
0.008	O
)	O
whist	O
taking	O
NK3R	O
antagonist	O
.	O

These	O
women	O
also	O
reported	O
a	O
reduction	O
in	O
hot	O
flash	I:C0600142
frequency	O
(	O
3.4	O
±	O
1.2	O
to	O
1.0	O
±	O
0.6	O
hot	B:C0600142
flashes	I:C0600142
/	O
day	O
,	O
p	O
=	O
0.008	O
)	O
whist	O
taking	O
NK3R	O
antagonist	O
.	O

These	O
women	O
also	O
reported	O
a	O
reduction	O
in	O
hot	O
flash	I:C0600142
frequency	O
(	O
3.4	O
±	O
1.2	O
to	O
1.0	O
±	O
0.6	O
hot	O
flashes	I:C0600142
/	O
day	O
,	O
p	O
=	O
0.008	O
)	O
whist	O
taking	O
NK3R	B:C0068603
antagonist	O
.	O

These	O
women	O
also	O
reported	O
a	O
reduction	O
in	O
hot	O
flash	I:C0600142
frequency	O
(	O
3.4	O
±	O
1.2	O
to	O
1.0	O
±	O
0.6	O
hot	O
flashes	I:C0600142
/	O
day	O
,	O
p	O
=	O
0.008	O
)	O
whist	O
taking	O
NK3R	O
antagonist	B:C0243076
.	O

Kisspeptin	B:C1721258
-	I:C1721258
10	I:C1721258
did	O
not	O
affect	O
LH	O
secretion	O
with	O
or	O
without	O
NK3R	O
antagonist	O
.	O

Kisspeptin	O
-	I:C1721258
10	I:C1721258
did	O
not	O
affect	O
LH	B:C0023607
secretion	O
with	O
or	O
without	O
NK3R	O
antagonist	O
.	O

Kisspeptin	O
-	I:C1721258
10	I:C1721258
did	O
not	O
affect	O
LH	O
secretion	B:C0036536
with	O
or	O
without	O
NK3R	O
antagonist	O
.	O

Kisspeptin	O
-	I:C1721258
10	I:C1721258
did	O
not	O
affect	O
LH	O
secretion	O
with	O
or	O
without	O
NK3R	B:C0068603
antagonist	O
.	O

Kisspeptin	O
-	I:C1721258
10	I:C1721258
did	O
not	O
affect	O
LH	O
secretion	O
with	O
or	O
without	O
NK3R	O
antagonist	B:C0243076
.	O

The	O
administration	B:C1533734
of	O
a	O
NK3R	O
antagonist	O
indicates	O
a	O
role	O
for	O
Neurokinin	O
B	I:C0027847
in	O
the	O
regulation	O
of	O
LH	O
/	O
GnRH	O
in	O
postmenopausal	O
women	O
whereas	O
the	O
lack	O
of	I:C1320680
response	I:C1320680
to	O
kisspeptin	O
may	O
reflect	O
the	O
hypoestrogenic	O
state	I:C0243095
.	O

The	O
administration	O
of	O
a	O
NK3R	B:C0068603
antagonist	O
indicates	O
a	O
role	O
for	O
Neurokinin	O
B	I:C0027847
in	O
the	O
regulation	O
of	O
LH	O
/	O
GnRH	O
in	O
postmenopausal	O
women	O
whereas	O
the	O
lack	O
of	I:C1320680
response	I:C1320680
to	O
kisspeptin	O
may	O
reflect	O
the	O
hypoestrogenic	O
state	I:C0243095
.	O

The	O
administration	O
of	O
a	O
NK3R	O
antagonist	B:C0243076
indicates	O
a	O
role	O
for	O
Neurokinin	O
B	I:C0027847
in	O
the	O
regulation	O
of	O
LH	O
/	O
GnRH	O
in	O
postmenopausal	O
women	O
whereas	O
the	O
lack	O
of	I:C1320680
response	I:C1320680
to	O
kisspeptin	O
may	O
reflect	O
the	O
hypoestrogenic	O
state	I:C0243095
.	O

The	O
administration	O
of	O
a	O
NK3R	O
antagonist	O
indicates	O
a	O
role	O
for	O
Neurokinin	B:C0027847
B	I:C0027847
in	O
the	O
regulation	O
of	O
LH	O
/	O
GnRH	O
in	O
postmenopausal	O
women	O
whereas	O
the	O
lack	O
of	I:C1320680
response	I:C1320680
to	O
kisspeptin	O
may	O
reflect	O
the	O
hypoestrogenic	O
state	I:C0243095
.	O

The	O
administration	O
of	O
a	O
NK3R	O
antagonist	O
indicates	O
a	O
role	O
for	O
Neurokinin	O
B	I:C0027847
in	O
the	O
regulation	B:C1327622
of	O
LH	O
/	O
GnRH	O
in	O
postmenopausal	O
women	O
whereas	O
the	O
lack	O
of	I:C1320680
response	I:C1320680
to	O
kisspeptin	O
may	O
reflect	O
the	O
hypoestrogenic	O
state	I:C0243095
.	O

The	O
administration	O
of	O
a	O
NK3R	O
antagonist	O
indicates	O
a	O
role	O
for	O
Neurokinin	O
B	I:C0027847
in	O
the	O
regulation	O
of	O
LH	B:C0023607
/	O
GnRH	O
in	O
postmenopausal	O
women	O
whereas	O
the	O
lack	O
of	I:C1320680
response	I:C1320680
to	O
kisspeptin	O
may	O
reflect	O
the	O
hypoestrogenic	O
state	I:C0243095
.	O

The	O
administration	O
of	O
a	O
NK3R	O
antagonist	O
indicates	O
a	O
role	O
for	O
Neurokinin	O
B	I:C0027847
in	O
the	O
regulation	O
of	O
LH	O
/	O
GnRH	B:C0023610
in	O
postmenopausal	O
women	O
whereas	O
the	O
lack	O
of	I:C1320680
response	I:C1320680
to	O
kisspeptin	O
may	O
reflect	O
the	O
hypoestrogenic	O
state	I:C0243095
.	O

The	O
administration	O
of	O
a	O
NK3R	O
antagonist	O
indicates	O
a	O
role	O
for	O
Neurokinin	O
B	I:C0027847
in	O
the	O
regulation	O
of	O
LH	O
/	O
GnRH	O
in	O
postmenopausal	B:C0232970
women	O
whereas	O
the	O
lack	O
of	I:C1320680
response	I:C1320680
to	O
kisspeptin	O
may	O
reflect	O
the	O
hypoestrogenic	O
state	I:C0243095
.	O

The	O
administration	O
of	O
a	O
NK3R	O
antagonist	O
indicates	O
a	O
role	O
for	O
Neurokinin	O
B	I:C0027847
in	O
the	O
regulation	O
of	O
LH	O
/	O
GnRH	O
in	O
postmenopausal	O
women	B:C0043210
whereas	O
the	O
lack	O
of	I:C1320680
response	I:C1320680
to	O
kisspeptin	O
may	O
reflect	O
the	O
hypoestrogenic	O
state	I:C0243095
.	O

The	O
administration	O
of	O
a	O
NK3R	O
antagonist	O
indicates	O
a	O
role	O
for	O
Neurokinin	O
B	I:C0027847
in	O
the	O
regulation	O
of	O
LH	O
/	O
GnRH	O
in	O
postmenopausal	O
women	O
whereas	O
the	O
lack	B:C1320680
of	I:C1320680
response	I:C1320680
to	O
kisspeptin	O
may	O
reflect	O
the	O
hypoestrogenic	O
state	I:C0243095
.	O

The	O
administration	O
of	O
a	O
NK3R	O
antagonist	O
indicates	O
a	O
role	O
for	O
Neurokinin	O
B	I:C0027847
in	O
the	O
regulation	O
of	O
LH	O
/	O
GnRH	O
in	O
postmenopausal	O
women	O
whereas	O
the	O
lack	O
of	I:C1320680
response	I:C1320680
to	O
kisspeptin	B:C3146273
may	O
reflect	O
the	O
hypoestrogenic	O
state	I:C0243095
.	O

The	O
administration	O
of	O
a	O
NK3R	O
antagonist	O
indicates	O
a	O
role	O
for	O
Neurokinin	O
B	I:C0027847
in	O
the	O
regulation	O
of	O
LH	O
/	O
GnRH	O
in	O
postmenopausal	O
women	O
whereas	O
the	O
lack	O
of	I:C1320680
response	I:C1320680
to	O
kisspeptin	O
may	O
reflect	O
the	O
hypoestrogenic	B:C0243095
state	I:C0243095
.	O

These	O
data	O
support	O
a	O
link	O
between	O
LH	B:C0023607
/	O
GnRH	O
pulsatility	O
and	O
vasomotor	O
symptoms	O
and	O
NK3R	O
antagonism	O
as	O
a	O
potential	O
therapeutic	O
approach	I:C0087111
.	O

These	O
data	O
support	O
a	O
link	O
between	O
LH	O
/	O
GnRH	B:C0023610
pulsatility	O
and	O
vasomotor	O
symptoms	O
and	O
NK3R	O
antagonism	O
as	O
a	O
potential	O
therapeutic	O
approach	I:C0087111
.	O

These	O
data	O
support	O
a	O
link	O
between	O
LH	O
/	O
GnRH	O
pulsatility	O
and	O
vasomotor	O
symptoms	O
and	O
NK3R	B:C0068603
antagonism	O
as	O
a	O
potential	O
therapeutic	O
approach	I:C0087111
.	O

These	O
data	O
support	O
a	O
link	O
between	O
LH	O
/	O
GnRH	O
pulsatility	O
and	O
vasomotor	O
symptoms	O
and	O
NK3R	O
antagonism	O
as	O
a	O
potential	O
therapeutic	B:C0087111
approach	I:C0087111
.	O

